We are studying the safety and how bimekizumab moves in the body for children aged 2 to under 18 with certain types of juvenile idiopathic arthritis. This research aims to help improve treatment options for these young patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Juvenile arthritis encompasses several types of inflammatory arthritis that affect children, including juvenile idiopathic arthritis, enthesitis-related arthritis, and juvenile psoriatic arthritis. These conditions can cause joint pain, swelling, and stiffness, impacting a child's mobility and quality of life.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
